Guidance
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm - update 15 March 2022
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
Authors
Languages
- English
Publication year
2021
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- COVID-19
Countries
- China
Tags
- New vaccine introduction
